P. H. Capital (500143)

Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Trading at P/B of 0.93, below book value of ₹198.81
• ROCE of 21.75% suggests decent operational capital efficiency historically
• No debt on the balance sheet (Debt/Equity N/A indicates no leverage)
• Potential hidden value in the investment portfolio as an investment company
• 52-week low of ₹165.05 provides some support near current price

Concerns

• Sales growth collapsed -97.92%, recent quarter sales only ₹2 Cr
• Profit growth -160.87%, latest quarter net loss of ₹-1 Cr, ROE -3.17%
• Piotroski F-Score of 3/9 signals weak financial health
• Dividend yield negligible at 0.04%; no income while waiting
• Price fell from ₹785 to ₹185.60, reflecting severe value destruction

AI Analysis

Let me look at P. H. Capital through Graham's lens. The first thing that catches my eye is that the stock trades at ₹185.60 against a book value of ₹198.81, a price-to-book of 0.93. That is a margin of safety, yes, but a cheap price can be a trap if the business itself is deteriorating. And deterioration is staring at me from every corner. Sales growth has collapsed by 97.92%, and profits are down 160.87%. The latest quarter tells the story: ₹2 crore in sales and a ₹1 crore net loss. This is not a temporary hiccup; this is a business that has lost its earning power. The Piotroski F-score of 3 out of 9 is a clear warning sign—financial health is weak. ROE is negative at -3.17%, meaning shareholder capital is being eroded. Interestingly, ROCE is 21.75%, but that likely reflects historical capital employed or operating quirks, not current net profitability. With a dividend yield of 0.04%, I am not being paid to wait. The 52-week range is breathtaking: from ₹785 down to ₹165, and now ₹185.60. The market has repriced this company harshly. Is there a hidden gem in the investment portfolio? Perhaps. But as an investor, I cannot rely on an unknown asset mix to rescue me. In Graham's words, this is a cigar butt—maybe one puff left, but no sustainable business. I would not classify this as a turnaround until I see a quarter of positive net profit and evidence that the sales collapse has bottomed. For now, it is an asset play with a discount to book, but not a quality compounder.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer